Amit Hasija's Insider Trades & SAST Disclosures

Amit Hasija's most recent trade in Milestone Pharmaceuticals Inc was a trade of 50,000 Common Shares done . Disclosure was reported to the exchange on July 11, 2025.

Share

Note

This is a custom search result for pattern Amit Hasija.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2025	50,000	50,000 (0%)	0%		-	Common Shares
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2025	50,000	50,000	-		-	Series A Common Warrants (right to buy)
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2025	50,000	50,000	-		-	Series B Common Warrants (right to buy)
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	120,600	120,600	-		-	Employee Stock Option (right to buy)
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	80,400	80,400	-		-	Restricted Stock Unit
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	130,000	130,000	-		-	Employee Stock Option (right to buy)
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Mar 2022	175,000	175,000	-		-	Employee Stock Option Grant (right to buy)
Milestone Pharmaceuticals Inc	Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Mar 2021	240,000	240,000	-		-	Employee Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades